SCM
CCXI

Suvretta Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Suvretta Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-45,000
Closed -$2.47M – 132
2020
Q3 		$2.47M Hold
45,000
– – 0.04% 78
2020
Q2 		$2.59M Buy
+45,000
New +$2.45M 0.06% 66

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Suvretta Capital Management's CCXI Position: Q2 2020 in Review

Suvretta Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q2 2020, closing a stake of 16,000 shares — an estimated $871K sold.

Suvretta Capital Management first reported a position in CCXI in Q1 2020 and held it in 1 quarter. The position peaked at $643K in Q1 2020. 193 funds tracked by Wall St. Rank hold CCXI as of Q2 2020.

  • Suvretta Capital Management reported no remaining ChemoCentryx, Inc. position as of Q2 2020 after selling out during the quarter.
  • Suvretta Capital Management sold 16,000 ChemoCentryx, Inc. shares in Q2 2020, an estimated $871K.
  • Suvretta Capital Management first reported a position in ChemoCentryx, Inc. in Q1 2020 and held it in 1 quarter.
  • Suvretta Capital Management's ChemoCentryx, Inc. position peaked at $643K in Q1 2020.
  • 193 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2020.

Based on Suvretta Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.